These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Parr MJ; Ansell SM; Choi LS; Cullis PR Biochim Biophys Acta; 1994 Oct; 1195(1):21-30. PubMed ID: 7918562 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Song LY; Ahkong QF; Rong Q; Wang Z; Ansell S; Hope MJ; Mui B Biochim Biophys Acta; 2002 Jan; 1558(1):1-13. PubMed ID: 11750259 [TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Holland JW; Hui C; Cullis PR; Madden TD Biochemistry; 1996 Feb; 35(8):2618-24. PubMed ID: 8611565 [TBL] [Abstract][Full Text] [Related]
8. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Maurer N; Wong KF; Stark H; Louie L; McIntosh D; Wong T; Scherrer P; Semple SC; Cullis PR Biophys J; 2001 May; 80(5):2310-26. PubMed ID: 11325732 [TBL] [Abstract][Full Text] [Related]
12. [Construction and evaluation of non-specific targeting cationic polymer lipid liposomes]. Chen T; Wang RT; Wang Z; Lu TL; Zhao W Yao Xue Xue Bao; 2010 Mar; 45(3):359-64. PubMed ID: 21351513 [TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Sou K; Endo T; Takeoka S; Tsuchida E Bioconjug Chem; 2000; 11(3):372-9. PubMed ID: 10821653 [TBL] [Abstract][Full Text] [Related]
14. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464 [TBL] [Abstract][Full Text] [Related]
16. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. Li W; Huang Z; MacKay JA; Grube S; Szoka FC J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149 [TBL] [Abstract][Full Text] [Related]
17. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Zalipsky S; Mullah N; Harding JA; Gittelman J; Guo L; DeFrees SA Bioconjug Chem; 1997; 8(2):111-8. PubMed ID: 9095350 [TBL] [Abstract][Full Text] [Related]
19. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether. Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302 [TBL] [Abstract][Full Text] [Related]
20. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]